Orwin John A

Director at Travere Therapeutics, Inc. · on record since May 21, 2026
Director at CARGO Therapeutics, Inc. · on record since Nov 13, 2023
PRESIDENT & CEO at Atreca, Inc. · on record since Jun 19, 2019
Director at NeurogesX Inc · on record since Nov 23, 2009
Director at Relypsa Inc · on record since Nov 20, 2013
President & CEO at Relypsa Inc · on record since Nov 20, 2013
Director at AFFYMAX INC · on record since Feb 2, 2011
CEO at AFFYMAX INC · on record since Feb 2, 2011
Director at ANAPTYSBIO, INC · on record since Apr 22, 2026
Director at First Tracks Biotherapeutics, Inc. · on record since Apr 22, 2026
Director at ARRAY BIOPHARMA INC · on record since Nov 7, 2012
Director at Seagen Inc. · on record since Jan 14, 2014
Director at Atreca, Inc. · on record since Jun 19, 2019

Insider trading activity of Orwin John A

Transactions on record: 251; since Nov 23, 2009

Open-market buys: 4; $298.4K

Open-market sells: 30; $8.6M

Companies traded: 10; last filing Sep 17, 2026

Figures computed from official regulatory filings — .

Companies where Orwin John A has traded

ANAPTYSBIO, INC32 tx · Sep 17, 2026
First Tracks Biotherapeutics, Inc.16 tx · Sep 17, 2026
Travere Therapeutics, Inc.20 tx · May 21, 2026
5 tx · Aug 19, 2025
17 tx · $122.4K · Apr 17, 2024
31 tx · $7.2M · Dec 15, 2023
25 tx · $801.5K · Jul 30, 2019
47 tx · $7M · Sep 2, 2016
53 tx · $6M · Jun 28, 2013
5 tx · Jun 11, 2012

Track record of Orwin John A

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Orwin John A

Co-insiders of Orwin John A

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
ANAPTYSBIO, INCListing on record	Sep 17, 2026	Exercise	1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Sep 17, 2026	ExerciseD (derivative)	-1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Sep 17, 2026	ExerciseD (derivative)	-1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Sep 17, 2026	Exercise	1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Jun 17, 2026	Exercise	6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Jun 17, 2026	ExerciseD (derivative)	-6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 17, 2026	ExerciseD (derivative)	-6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 17, 2026	Exercise	6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 12, 2026	AwardD (derivative)	7,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 12, 2026	AwardD (derivative)	2,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	AwardD (derivative)	12,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	Award	4,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	May 14, 2026	AwardD (derivative)	42,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	May 14, 2026	AwardD (derivative)	15,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	3,311	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	16,510	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	8,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	10,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	OtherD (derivative)	-16,510	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	8,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	10,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	OtherD (derivative)	-16,510	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	OtherD (derivative)	-8,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Value · USD	Src
ANAPTYSBIO, INCListing on record	Sep 17, 2026	Exercise	1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Sep 17, 2026	ExerciseD (derivative)	-1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Sep 17, 2026	ExerciseD (derivative)	-1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Sep 17, 2026	Exercise	1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Jun 17, 2026	Exercise	6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Jun 17, 2026	ExerciseD (derivative)	-6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 17, 2026	ExerciseD (derivative)	-6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 17, 2026	Exercise	6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 12, 2026	AwardD (derivative)	7,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Jun 12, 2026	AwardD (derivative)	2,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	AwardD (derivative)	12,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Travere Therapeutics, Inc.Listing on record	May 21, 2026	Award	4,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	May 14, 2026	AwardD (derivative)	42,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	May 14, 2026	AwardD (derivative)	15,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	3,311	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	16,510	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	8,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	10,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	OtherD (derivative)	-16,510	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	8,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	AwardD (derivative)	10,600	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	6,030	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	OtherD (derivative)	-16,510	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
ANAPTYSBIO, INCListing on record	Apr 22, 2026	OtherD (derivative)	-8,250	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
First Tracks Biotherapeutics, Inc.Listing unverified	Apr 22, 2026	AwardD (derivative)	1,300	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC